TROG 13.01 – SAFRON II Dataset

Dataset Name:

TROG 13.01 SAFRON II Stereotactic ablative fractionated radiotherapy versus radiosurgery for oligometastatic neoplasia to the lung: A randomised phase II trial

DOI:

10.58118/zb3r-km05

Publisher:

TROG Cancer Research

Creator(s):

A/Prof Shankar Siva

Contributor(s):

Australian Lung Cancer Trials Group (ALTG)

Date made available:

2023

Dataset:

Individual Participant Data

Subject (ANZSRC Category):

Radiation therapy

Patient sample size:

90

Dataset Description:

Dataset Contains:
– Toxicity grade 3 or higher related to SABR treatment
– Quality of life (EQ-5D and MDASI-LC)
– Time to local failure
– Overall survival
– Time to distant failure
– Disease free survival
– Resources use and costs associated with treatment (MBS/PBS data. Hospitalisations. QALYs)
– Imaging data (CT)
– Approx time period of data collection 2015-2021

Radiotherapy Quality Assurance
– 89 RTQA imaging datasets
– 22 benchmarking datasets
– RT plans, RT delivery and imaging documentation, LRF (DICOM format)

Funding:

Cancer Australia, Auckland Medical Research Foundation

Keywords (MeSH):

Dose Fractionation, Radiation*; Health Care Costs; Health Resources; Humans; Lung Neoplasms/diagnosis; Lung Neoplasms/secondary*; Lung Neoplasms/therapy*; Quality of Life; Radiosurgery*/economics; Radiosurgery*/methods; Radiotherapy/economics; Radiotherapy/methods*; Tomography, X-Ray Computed; Tumor Burden

ANZCTR Reference:

ACTRN12613001157763

Publications:

A randomised phase II trial of Stereotactic Ablative Fractionated radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the lung (TROG 13.01 SAFRON II)

https://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2227-z

Requests for Data:

Access can be requested via the Health Data Australia catalogue. Search for the ACTRN number in the catalogue to find datasets associated with this trial or email enquiries to trials@trog.com.au.

Please submit a New Trial Proposal Application (Category D) to the TROG Cancer Research Operations Executive Committee.

TROG 13.01 – SAFRON II Dataset

https://bmccancer.biomedcentral.com/articles/10.1186/s12885-016-2227-z

Register for the 2025 ASM